Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom: Supplemental Materials
Langham, S, Wright, A, Kenworthy, J, Grieve, R
and Dunlop, WC
(2018).
Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom: Supplemental Materials.
[Dataset].
Value in Health.
https://doi.org/10.1016/j.jval.2017.07.014
Input parameters and ranges for Naloxone distribution model parameters, with detailed rationale for parameter selection. Model built in Microsoft Excel 2016 and subsequently reproduced in R version 3.3.2 and validated against the Excel version.
Keywords
Cost-effectiveness, Death, Drug overdose, Economic model, Heroin addiction, Naloxone, Preventative measures, Quality-adjusted life-yearsItem Type | Dataset |
---|---|
Capture method | Simulation |
Date | 4 February 2018 |
Language(s) of written materials | English |
Creator(s) |
Langham, S, Wright, A, Kenworthy, J, Grieve, R |
LSHTM Faculty/Department | Faculty of Public Health and Policy > Dept of Health Services Research and Policy |
Participating Institutions | Maverex Ltd., Manchester, United Kingdom, Mundipharma International Ltd., Cambridge, United Kingdom, London School of Hygiene & Tropical Medicine, London, United Kingdom |
Date Deposited | 02 May 2018 16:39 |
Last Modified | 08 Jul 2021 12:52 |
Publisher | Value in Health |
No files available. Please consult associated links.
- Publication - Value in Health (Online Data Resource)
Downloads
ORCID: https://orcid.org/0000-0001-8899-1301